Premier Biomedical, Inc. (BIEI)

Premier Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	0	0	0.01
Revenue Growth (YoY)	-	-	-	-	-92.86%	-64.11%
Cost of Revenue	0	0	0	0	0	0.01
Gross Profit	0	0	-0	-0	-0	0
Selling, General & Admin	0.17	0.17	0.02	0.01	0.1	0.33
Operating Expenses	0.17	0.17	0.02	0.01	0.1	0.33
Operating Income	-0.17	-0.17	-0.02	-0.01	-0.1	-0.33
Interest Expense	0.03	0.03	0.03	0.03	0.3	0.39
Other Expense / Income	-0	0	-0	-0	-0	-0.74
Pretax Income	-0.2	-0.2	-0.05	-0.04	-0.4	-0.37
Income Tax	0	0	0	0	0	0.39
Net Income	-0.2	-0.2	-0.05	-0.04	-0.4	-0.37
Shares Outstanding (Basic)	1,099	1,099	1,099	1,000	797	52
Shares Outstanding (Diluted)	1,099	1,099	1,099	1,000	797	52
Shares Change	-	-	9.89%	25.55%	1419.98%	1394.89%
EPS (Basic)	-0.00	-0.00	-	-	-0.00	-0.01
EPS (Diluted)	-0.00	-0.00	-	-	-0.00	-0.01
Free Cash Flow	-0.17	-0.17	0	-0.01	-0.07	-0.35
Free Cash Flow Per Share	-0.00	-0.00	0.00	-0.00	-0.00	-0.01
Gross Margin	-	-	-	-	-123.55%	9.95%
Operating Margin	-	-	-	-	-9895.00%	-2287.90%
Profit Margin	-	-	-	-	-39564.97%	-2622.16%
Free Cash Flow Margin	-	-	-	-	-6986.95%	-2444.02%
EBITDA	-0.17	-0.17	-0.02	-0.01	-0.1	-0.32
EBITDA Margin	-	-	-	-	-9701.67%	-2268.08%
Depreciation & Amortization	0	0	0	0	0	0
EBIT	-	-	-0.02	-0.01	-0.1	-0.33
EBIT Margin	-	-	-	-	-9894.60%	-2287.90%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.